Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22932717 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed LCZ696 Compared to Valsartan in Patients With Chronic Heart Failure and Preserved Left-ventricular Ejection Fraction
Condition: Chronic Heart Failure
Interventions: Drug: LCZ696;   Drug: Valsartan

Indicates status has not been verified in more than two years